Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TMEM39B |
| Upstream (Parents) |
|---|
| (<<) ASNS → TMEM39B |
| (<<) AVP → TMEM39B |
| (<<) CEBPB → TMEM39B |
| (<<) COTL1 → TMEM39B |
| (<<) CSNK1A1 → TMEM39B |
| (<<) CTPS → TMEM39B |
| (<<) ELF4 → TMEM39B |
| (<<) EWSR1 → TMEM39B |
| (<<) GSK3B → TMEM39B |
| (<<) IL1R2 → TMEM39B |
| (<<) MAP3K6 → TMEM39B |
| (<<) NRIP1 → TMEM39B |
| (<<) PIK3CD → TMEM39B |
| (<<) PPRC1 → TMEM39B |
| (<<) PRKCSH → TMEM39B |
| (<<) PTEN → TMEM39B |
| (<<) RRP1 → TMEM39B |
| (<<) RXRA → TMEM39B |
| (<<) STK40 → TMEM39B |
| (<<) TCF7L1 → TMEM39B |
| (<<) TFF1 → TMEM39B |
| (<<) TMEM87B → TMEM39B |
| (<<) TUBA1C → TMEM39B |
| (<<) UGDH → TMEM39B |
| Downstream (Children) |
|---|
| TMEM39B → ADAM19 (>>) |
| TMEM39B → ADCY3 (>>) |
| TMEM39B → CCNE1 (>>) |
| TMEM39B → CDKN2A (>>) |
| TMEM39B → CHI3L1 (>>) |
| TMEM39B → CHODL (>>) |
| TMEM39B → CXCL3 (>>) |
| TMEM39B → EFNB1 (>>) |
| TMEM39B → EPHB6 (>>) |
| TMEM39B → FOXO3 (>>) |
| TMEM39B → GPRIN2 (>>) |
| TMEM39B → HDAC5 (>>) |
| TMEM39B → KHDRBS1 (>>) |
| TMEM39B → LOC100131262 (>>) |
| TMEM39B → MAPK12 (>>) |
| TMEM39B → MAPK7 (>>) |
| TMEM39B → MMP9 (>>) |
| TMEM39B → MYL6B (>>) |
| TMEM39B → NAV2 (>>) |
| TMEM39B → RPS6KA1 (>>) |
| TMEM39B → TCEAL1 (>>) |
| TMEM39B → TRAF2 (>>) |
